LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00567619
First received: September 20, 2007
Last updated: February 14, 2008
Last verified: February 2008
  Purpose

Evaluate burden of disease in Patients with newly occurred upper GI symptoms related to GERD (symptom frequency & severity, QoL, lifestyle modifications, self-medication) - baseline data according to GERD impact scale presenting to specialists, especially internists

- Evaluate effect of treatment with a acid suppressive therapy on these parameters: looking for improvement of symptom burden and quality of life according to the GERD impact sca


Condition
GERD

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

Further study details as provided by AstraZeneca:

Estimated Enrollment: 900
Study Start Date: July 2007
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with newly occured upper GI symptoms related to GERD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00567619

Locations
Austria
Research Site
Vienna, Austria
Sponsors and Collaborators
AstraZeneca
Investigators
Study Chair: Not required for Study Not required for this study
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00567619     History of Changes
Other Study ID Numbers: NIS-GAT-NEX-2007/1
Study First Received: September 20, 2007
Last Updated: February 14, 2008
Health Authority: Not required for this study:

Keywords provided by AstraZeneca:
GERD
NIS

ClinicalTrials.gov processed this record on October 21, 2014